Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Other Working Capital Changes of -$4.9 million in Q4 2025, down 691.23% quarter-over-quarter from $821000.0 in Q3 2025, and down 174.08% on a YoY basis from $6.6 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Working Capital Changes history runs 16 years deep, the most recent figure standing at -$4.9 million for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 174.08% year-over-year to -$4.9 million; the TTM figure through Dec 2025 stood at $7.8 million (up 595.99% YoY), while the FY2025 annual figure was -$4.7 million, down 156.67% from the prior year.
- Other Working Capital Changes was -$4.9 million for Q4 2025 at Prestige Consumer Healthcare, down from $821000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $10.9 million in Q2 2025 to a low of -$7.1 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged $340400.0 across 5 years, with a median of $148500.0 in 2021.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes sank 16541.86% in 2022, then jumped 7366.67% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at $5.5 million in 2021, then tumbled by 99.89% to $6000.0 in 2022, then surged by 7366.67% to $448000.0 in 2023, then slumped by 495.31% to -$1.8 million in 2024, then tumbled by 174.08% to -$4.9 million in 2025.
- The last three Other Working Capital Changes figures came in at -$4.9 million (Q4 2025), $821000.0 (Q3 2025), and $10.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Sep 30, 2025 | 821,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Jun 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 903,000.00 |
| Mar 31, 2025 | 903,000.00 |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Mar 31, 2024 | 6.68 Mn |
| Mar 31, 2024 | 6.68 Mn |
| Dec 31, 2023 | 448,000.00 |
| Dec 31, 2023 | 448,000.00 |
| Sep 30, 2023 | 831,000.00 |
| Sep 30, 2023 | 831,000.00 |